Supriya Lifescience Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

16.10

16.10

14.64

14.64

14.64

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

683.36

599.59

253.95

133.12

79.65

Loan funds

Secured loans

16.63

21.30

67.41

82.21

89.84

Unsecured loans

-

-

-

-

-

Total

716.08

636.98

335.99

229.97

184.13

Uses of funds

Fixed assets

Gross block

302.98

220.30

122.21

128.72

100.67

Less : revaluation reserve

-

-

-

2.13

2.30

Less : accumulated depreciation

41.44

30.53

22.17

31.99

18.16

Net block

261.54

189.77

100.04

94.60

80.20

Capital work-in-progress

67.63

43.41

78.79

40.21

35.35

Investments

25.30

0.05

0.05

0.05

0.05

Net current assets

Current assets, loans & advances

465.82

501.53

266.59

198.22

133.28

Less : current liabilities & provisions

104.19

97.78

109.47

103.12

64.76

Total net current assets

361.62

403.75

157.11

95.10

68.52

Miscellaneous expenses not written

-

-

-

-

-

Total

716.08

636.98

335.99

229.97

184.13

Notes:

Book value of unquoted investments

25.30

0.05

0.05

0.05

0.05

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

5.62

5.62

1.57

-

-

Number of equity sharesoutstanding (Lacs)

804.83

804.83

731.84

146.37

146.37